Rabourn Amy Zaremba - Jan 18, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Signature
/s/ Emily Johns, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/22/2024, 06:01 PM
Previous filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +40K +93.77% $0.00 82.7K Jan 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Employee Stock Option (right to buy) Award $0 +60K $0.00 60K Jan 18, 2024 Common Stock 60K $2.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
F2 The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.